These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31685470)

  • 21. Human fungal pathogen Candida albicans in the postgenomic era: an overview.
    Kabir MA; Hussain MA
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):121-34. PubMed ID: 19622061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the binding of a Helianthus annuus lectin to Candida albicans cell wall on biofilm development and adhesion to host cells.
    Del Rio M; de la Canal L; Pinedo M; Mora-Montes HM; Regente M
    Phytomedicine; 2019 May; 58():152875. PubMed ID: 30884454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cation Transporters of
    Volkova M; Atamas A; Tsarenko A; Rogachev A; Guskov A
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33923411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of proteomic analysis to the study of azole antifungal resistance in Candida albicans.
    Hooshdaran MZ; Hilliard GM; Rogers PD
    Methods Mol Med; 2005; 118():57-70. PubMed ID: 15888935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the
    Ajdidi A; Sheehan G; Abu Elteen K; Kavanagh K
    J Med Microbiol; 2019 Oct; 68(10):1497-1506. PubMed ID: 31460860
    [No Abstract]   [Full Text] [Related]  

  • 26. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
    Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doxorubicin induces drug efflux pumps in Candida albicans.
    Kofla G; Turner V; Schulz B; Storch U; Froelich D; Rognon B; Coste AT; Sanglard D; Ruhnke M
    Med Mycol; 2011 Feb; 49(2):132-42. PubMed ID: 20818920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering improved variants of the antifungal peptide histatin 5 with reduced susceptibility to Candida albicans secreted aspartic proteases and enhanced antimicrobial potency.
    Ikonomova SP; Moghaddam-Taaheri P; Jabra-Rizk MA; Wang Y; Karlsson AJ
    FEBS J; 2018 Jan; 285(1):146-159. PubMed ID: 29143452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting adhesion in fungal pathogen
    Martin H; Kavanagh K; Velasco-Torrijos T
    Future Med Chem; 2021 Feb; 13(3):313-334. PubMed ID: 32564615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.
    Henry KW; Cruz MC; Katiyar SK; Edlind TD
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1968-74. PubMed ID: 10428921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candida albicans Infection Model in Zebrafish (Danio rerio) for Screening Anticandidal Drugs.
    Kulatunga DCM; Dananjaya SHS; Nikapitiya C; Kim CH; Lee J; De Zoysa M
    Mycopathologia; 2019 Oct; 184(5):559-572. PubMed ID: 31473909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Vacuolar Ca
    Luna-Tapia A; DeJarnette C; Sansevere E; Reitler P; Butts A; Hevener KE; Palmer GE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30728284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antifungal effect of Echinophora platyloba on expression of CDR1 and CDR2 genes in fluconazole-resistant Candida albicans.
    Khajeh E; Hosseini Shokouh SJ; Rajabibazl M; Roudbary M; Rafiei S; Aslani P; Farahnejad Z
    Br J Biomed Sci; 2016; 73(1):44-8. PubMed ID: 27182677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antifungal plant defensin RsAFP2 from radish induces apoptosis in a metacaspase independent way in Candida albicans.
    Aerts AM; Carmona-Gutierrez D; Lefevre S; Govaert G; François IE; Madeo F; Santos R; Cammue BP; Thevissen K
    FEBS Lett; 2009 Aug; 583(15):2513-6. PubMed ID: 19596007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promising Antifungal Targets Against
    Li Y; Sun L; Lu C; Gong Y; Li M; Sun S
    Front Cell Infect Microbiol; 2018; 8():286. PubMed ID: 30234023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal Activity of Oleuropein against Candida albicans-The In Vitro Study.
    Zorić N; Kopjar N; Bobnjarić I; Horvat I; Tomić S; Kosalec I
    Molecules; 2016 Nov; 21(12):. PubMed ID: 27916806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two natural molecules preferentially inhibit azole-resistant Candida albicans with MDR1 hyperactivation.
    Shi HZ; Chang WQ; Zhang M; Lou HX
    Chin J Nat Med; 2019 Mar; 17(3):209-217. PubMed ID: 30910057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of validamycin as a potential antifungal compound against Candida albicans.
    Guirao-Abad JP; Sánchez-Fresneda R; Valentín E; Martínez-Esparza M; Argüelles JC
    Int Microbiol; 2013 Dec; 16(4):217-25. PubMed ID: 25102722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium lignosulfonate causes cell membrane perturbation in the human fungal pathogen Candida albicans.
    Jha A; Kumar A
    World J Microbiol Biotechnol; 2023 Apr; 39(6):164. PubMed ID: 37069369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.